CADL Annual Total Long Term Liabilities
$14.27 M
-$10.09 M-41.42%
31 December 2023
Summary:
As of January 23, 2025, CADL annual total long term liabilities is $14.27 million, with the most recent change of -$10.09 million (-41.42%) on December 31, 2023. During the last 3 years, it has fallen by -$42.86 million (-75.02%). CADL annual total long term liabilities is now -75.02% below its all-time high of $57.13 million, reached on December 31, 2020.CADL Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CADL Quarterly Long Term Liabilities
$21.51 M
-$955.00 K-4.25%
30 September 2024
Summary:
As of January 23, 2025, CADL quarterly total long term liabilities is $21.51 million, with the most recent change of -$955.00 thousand (-4.25%) on September 30, 2024. Over the past year, it has dropped by -$955.00 thousand (-4.25%). CADL quarterly long term liabilities is now -69.02% below its all-time high of $69.42 million, reached on June 30, 2021.CADL Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CADL Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.4% | -4.3% |
| 3 y3 years | -75.0% | -11.7% |
| 5 y5 years | -72.8% | -11.7% |
CADL Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.4% | at low | -33.5% | +83.8% |
| 5 y | 5-year | -75.0% | at low | -69.0% | +83.8% |
| alltime | all time | -75.0% | at low | -69.0% | +83.8% |
Candel Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $21.51 M(-4.3%) |
| June 2024 | - | $22.46 M(+92.0%) |
| Mar 2024 | - | $11.70 M(-18.0%) |
| Dec 2023 | $14.27 M(-41.4%) | $14.27 M(-14.6%) |
| Sept 2023 | - | $16.71 M(-15.5%) |
| June 2023 | - | $19.77 M(-11.5%) |
| Mar 2023 | - | $22.35 M(-8.3%) |
| Dec 2022 | $24.36 M | $24.36 M(-9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $26.98 M(-1.3%) |
| June 2022 | - | $27.35 M(-15.4%) |
| Mar 2022 | - | $32.33 M(+64.1%) |
| Dec 2021 | $19.71 M(-65.5%) | $19.71 M(-31.0%) |
| Sept 2021 | - | $28.58 M(-58.8%) |
| June 2021 | - | $69.42 M(+21.6%) |
| Mar 2021 | - | $57.09 M(-0.1%) |
| Dec 2020 | $57.13 M(+8.8%) | $57.13 M |
| Dec 2019 | $52.53 M | - |
FAQ
- What is Candel Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Candel Therapeutics?
- What is Candel Therapeutics annual total long term liabilities year-on-year change?
- What is Candel Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Candel Therapeutics?
- What is Candel Therapeutics quarterly long term liabilities year-on-year change?
What is Candel Therapeutics annual total long term liabilities?
The current annual total long term liabilities of CADL is $14.27 M
What is the all time high annual total long term liabilities for Candel Therapeutics?
Candel Therapeutics all-time high annual total long term liabilities is $57.13 M
What is Candel Therapeutics annual total long term liabilities year-on-year change?
Over the past year, CADL annual total long term liabilities has changed by -$10.09 M (-41.42%)
What is Candel Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of CADL is $21.51 M
What is the all time high quarterly long term liabilities for Candel Therapeutics?
Candel Therapeutics all-time high quarterly total long term liabilities is $69.42 M
What is Candel Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, CADL quarterly total long term liabilities has changed by -$955.00 K (-4.25%)